Enhabit, Inc. (NYSE:EHAB) Receives Average Rating of “Hold” from Brokerages

Shares of Enhabit, Inc. (NYSE:EHAB) have received an average recommendation of “Hold” from the nine analysts that are presently covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month price objective among brokers that have covered the stock in the last year is $13.5714.

A number of analysts have issued reports on EHAB shares. Jefferies Financial Group lowered Enhabit from a “buy” rating to a “hold” rating and raised their target price for the company from $12.50 to $13.80 in a report on Monday, February 23rd. TD Cowen reaffirmed a “hold” rating and issued a $13.80 target price (up from $12.00) on shares of Enhabit in a report on Friday, March 6th. UBS Group reaffirmed a “neutral” rating and issued a $13.80 target price (up from $12.00) on shares of Enhabit in a report on Tuesday, February 24th. Truist Financial set a $13.80 target price on Enhabit in a report on Monday, February 23rd. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Enhabit in a report on Tuesday, April 14th.

Insider Transactions at Enhabit

In other Enhabit news, EVP Julie Diane Jolley sold 2,793 shares of the firm’s stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $13.63, for a total value of $38,068.59. Following the sale, the executive vice president owned 139,923 shares of the company’s stock, valued at $1,907,150.49. This trade represents a 1.96% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 3.40% of the stock is owned by company insiders.

Institutional Trading of Enhabit

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Bailard Inc. acquired a new stake in Enhabit in the 3rd quarter valued at approximately $442,000. Segall Bryant & Hamill LLC bought a new stake in shares of Enhabit in the 3rd quarter worth approximately $1,926,000. 8 Knots Management LLC lifted its position in shares of Enhabit by 9.5% in the 3rd quarter. 8 Knots Management LLC now owns 4,218,846 shares of the company’s stock worth $33,793,000 after acquiring an additional 365,779 shares during the period. Y Intercept Hong Kong Ltd lifted its position in shares of Enhabit by 188.2% in the 3rd quarter. Y Intercept Hong Kong Ltd now owns 218,284 shares of the company’s stock worth $1,748,000 after acquiring an additional 142,556 shares during the period. Finally, State of Alaska Department of Revenue bought a new stake in shares of Enhabit in the 3rd quarter worth approximately $27,000.

Enhabit Stock Performance

Shares of NYSE EHAB opened at $13.80 on Monday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.56 and a current ratio of 1.56. The firm has a market cap of $706.97 million, a price-to-earnings ratio of -153.33 and a beta of 1.26. The business’s 50-day simple moving average is $13.79 and its 200-day simple moving average is $11.49. Enhabit has a 52 week low of $6.47 and a 52 week high of $14.22.

Enhabit (NYSE:EHAB) last issued its quarterly earnings data on Thursday, May 7th. The company reported $0.36 EPS for the quarter. The business had revenue of $264.80 million for the quarter. Enhabit had a positive return on equity of 7.24% and a negative net margin of 0.30%. As a group, equities research analysts expect that Enhabit will post 0.58 earnings per share for the current fiscal year.

About Enhabit

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.